The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127660531 12766053 1 I 20160915 20160921 20160921 EXP US-MLMSERVICE-20160909-0419529-1 US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK024336 GLENMARK SHARON N, CULLEN C, MARTINEZ K.. A COMPLEX PRESENTATION OF PEDIATRIC NEUROLEPTIC MALIGNANT SYNDROME RELATED TO POLYPHARMACY IN A 12-YEAR-OLD MALE.. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY.. 2015;26(6):571-573 0.00 Y 0.00000 20160921 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127660531 12766053 1 PS PRAMIPEXOLE DIHYDROCHLORIDE. PRAMIPEXOLE DIHYDROCHLORIDE 1 Unknown 0.125 MG, AT BEDTIME 90781 .125 MG
127660531 12766053 2 SS METHYLPHENIDATE ER METHYLPHENIDATE 1 Unknown 36 MG, ONCE IN MORNING 0 36 MG
127660531 12766053 3 SS PAROXETINE. PAROXETINE 1 Unknown 40 MG, ONCE IN THE MORNING 0 40 MG
127660531 12766053 4 SS RISPERIDONE. RISPERIDONE 1 Unknown 0.5 MG, BID 0 .5 MG BID
127660531 12766053 5 SS RISPERIDONE. RISPERIDONE 1 Unknown 0.5 MG, QD 0 .5 MG
127660531 12766053 6 SS RISPERIDONE. RISPERIDONE 1 Unknown 1 MG, QD AT BEDTIME 0 1 MG
127660531 12766053 7 SS VALPROIC ACID. VALPROIC ACID 1 Unknown 375 MG, QD IN THE MORNING 0 375 MG
127660531 12766053 8 SS VALPROIC ACID. VALPROIC ACID 1 Unknown 500 MG, AT BEDTIME 0 500 MG
127660531 12766053 9 C MELATONIN MELATONIN 1 Unknown 5 MG, AT BEDTIME AS NEEDED FOR SLEEP 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127660531 12766053 1 Product used for unknown indication
127660531 12766053 2 Product used for unknown indication
127660531 12766053 3 Product used for unknown indication
127660531 12766053 4 Product used for unknown indication
127660531 12766053 7 Product used for unknown indication
127660531 12766053 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127660531 12766053 HO
127660531 12766053 LT
127660531 12766053 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127660531 12766053 Neuroleptic malignant syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found